Regenerative medicine is the repair or replacement of damaged tissues and organs through the use of cells, biomaterials and molecular therapies. Major breakthroughs include stem cell therapies (i.e. induced pluripotent stem cells, ESCs, MSCs), precise gene editing (CRISPR/Cas9) and engineered tissues by means of 3D bio-printing. Artificial intelligence and big data are driving discovery in this field. There are promising clinical trials underway, patient derived cells have improved retinal burns and heart function for example. Major applications are under development in cardiology (repair of heart), neurology (neuronal regeneration), and orthopedics (repair of bone and cartilage). But there are difficulties. Immune rejection. Cancer risk. Ethical questions (use of embryos, human cloning). Future directions include combining approaches: gene-edited universal donor tissues, vascularized organoids and advanced bioreactors. As techniques mature, the future of regenerative medicine for chronic diseases and trauma looks promising. This review summarizes current breakthroughs, real world applications, ethical concerns and future prospects.